Recs

1

2 Generics of Pfizer's Revatio OK'd

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Pharmaceutical companies Mylan (Nasdaq: MYL  ) and Watson Pharmaceuticals (NYSE: WPI  ) have announced that they have received FDA approval for generic versions of Pfizer's (NYSE: PFE  ) Revatio, a drug used to combat pulmonary arterial hypertension, or high blood pressure in the lungs. Revatio also contains sildenafil, which is the same component included in the erectile dysfunction treatment Viagra.

Mylan received approval for sildenafil citrate tablets, 20 mg. Watson got the OK for sildenafil tablets, 20 mg,

Revatio tablets, 20 mg, had almost $340 million in U.S. sales in the 12 months ended Sept. 30, 2012, according to Mylan's press release. Mylan boasts a portfolio of more than 1,100 generic offerings, and has another 172 Abbreviated New Drug Applications pending with the FDA. Watson Pharmaceuticals is the world's third-largest generics prescription drug manufacturer, with more than 750 products marketed globally.


Read/Post Comments (0) | Recommend This Article (1)

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2110301, ~/Articles/ArticleHandler.aspx, 10/1/2016 3:35:33 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 6 hours ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 4:03 PM
AGN $230.31 Down -0.49 -0.21%
Allergan CAPS Rating: ****
MYL $38.12 Down -0.35 -0.91%
Mylan CAPS Rating: ***
PFE $33.87 Up +0.55 +1.65%
Pfizer CAPS Rating: ****